# Filing Detail

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0000950144-07-006504
Filing Date
2007-07-11
Accepted
2007-07-11 17:00:09
Documents
27

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | CUMBERLAND PHARMACEUTICALS INC. | g06286a3sv1za.htm | S-1/A | 105867
2 | EX-4.6.1 FORM OF INCENTIVE STOCK OPTION AGREEMENT UNDER LONG-TERM INCENTIVE COMP | g06286a3exv4w6w1.htm | EX-4.6.1 | 19171
3 | EX-4.6.2 FORM OF NONSTATUTORY STOCK OPTION AGREEMENT UNDER LONG-TERM INCENTIVE C | g06286a3exv4w6w2.htm | EX-4.6.2 | 19061
4 | EX-4.7 FORM OF NONSTATUTORY STOCK OPTION AGREEMENT UNDER DIRECTORS' COMPENSATION | g06286a3exv4w7.htm | EX-4.7 | 18313
5 | EX-10.1 MANUFACTURING AND SUPPLY AGREEMENT | g06286a3exv10w1.htm | EX-10.1 | 149473
6 | EX-10.3 FIRST AMENDMENT TO MANUFACTURING AND SUPPLY AGREEMENT | g06286a3exv10w3.htm | EX-10.3 | 30661
7 | EX-10.4 CARDINAL HEALTH CONTRACT SALES AND SERVICE | g06286a3exv10w4.htm | EX-10.4 | 120758
8 | EX-10.5 FIRST AMENDMENT TO CONTRACT SALES AND SERVICE AGREEMENT | g06286a3exv10w5.htm | EX-10.5 | 17525
9 | EX-10.6 SECOND AMENDMENT TO CONTRACT SALES AND SERVICE AGREEMENT | g06286a3exv10w6.htm | EX-10.6 | 6195
10 | EX-10.7 DISTRIBUTION SERVICES AGREEMENT | g06286a3exv10w7.htm | EX-10.7 | 85671
11 | EX-10.8 STRATEGIC ALLIANCE AGREEMENT | g06286a3exv10w8.htm | EX-10.8 | 163593
12 | EX-10.9 KRISTALOSE AGREEMENT | g06286a3exv10w9.htm | EX-10.9 | 381994
13 | EX-10.10 LICENSE AGREEMENT | g06286a3exv10w10.htm | EX-10.10 | 50930
14 | EX-10.16.1 SECOND AMENDED AND RESTATED LOAN AGREEMENT | g06286a3exv10w16w1.htm | EX-10.16.1 | 247533
15 | EX-10.16.2 FIRST AMENDMENT TO SECOND AMENDED AND RESTATED LOAN AGREEMENT | g06286a3exv10w16w2.htm | EX-10.16.2 | 16794
16 | EX-10.21 LEASE AGREEMENT | g06286a3exv10w21.htm | EX-10.21 | 258620
17 | EX-10.22.1 SUBLEASE AGREEMENT, DAGED DECEMBER 14, 2006 | g06286a3exv10w22w1.htm | EX-10.22.1 | 399194
18 | EX-10.22.2 ADDENDUM TO SUBLEASE AGREEMENT | g06286a3exv10w22w2.htm | EX-10.22.2 | 33699
19 | GRAPHIC | g06286a3g0628604.gif | GRAPHIC | 266089
20 | GRAPHIC | g06286a3g0628605.gif | GRAPHIC | 60583
21 | GRAPHIC | g06286a3g0628631.gif | GRAPHIC | 30582
22 | GRAPHIC | g06286a3g0628632.gif | GRAPHIC | 60977
23 | GRAPHIC | g06286a3g0628633.gif | GRAPHIC | 50735
24 | GRAPHIC | g06286a3g0628634.gif | GRAPHIC | 10831
25 | GRAPHIC | g06286a3g0628635.gif | GRAPHIC | 45856
26 | GRAPHIC | g06286a3g0628606.gif | GRAPHIC | 24242
27 | GRAPHIC | g06286a3g0628612.gif | GRAPHIC | 137643
| Complete submission text file | 0000950144-07-006504.txt |  | 3074939

Mailing Address
Business Address 209 TENTH AVENUE SOUTH SUITE 332 NASHVILLE, TN 37203
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: S-1/A | Act: 33 | File No.: 333-142535 | Film No.: 07974707
SIC: 2834 Pharmaceutical Preparations